The immunoproteasome in antigen processing and other immunological functions

Current Opinion in Immunology

Volumn 25, Issue 1, 2013, Pages 74-80

  Basler, Michael ^a,b   Kirk, Christopher J ^c   Groettrup, Marcus ^a,b  

^a UNIVERSITY OF KONSTANZ   (Germany)

^b UNIVERSITY OF KONSTANZ   (Switzerland)

^c ONYX PHARMACEUTICALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOPROTEASOME; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR BETA; INTERLEUKIN 23; INTERLEUKIN 4; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PROTEASOME; PROTEIN LMP2; PROTEIN LMP7; PROTEIN MECL 1; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR T BET; UNCLASSIFIED DRUG;

ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; HUMAN; IMMUNITY; IMMUNOPATHOGENESIS; INFLAMMATORY DISEASE; LYMPHOCYTE DIFFERENTIATION; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW;

EID: 84875258216     PISSN: 09527915     EISSN: 18790372     Source Type: Journal    
DOI: 10.1016/j.coi.2012.11.004     Document Type: Review

References (55)

1. Kloetzel P.M. Generation of major histocompatibility complex class I antigens: functional interplay between proteasomes and TPPII. Nat Immunol 2004, 5:661-669.
2. Huber E.M., Basler M., Schwab R., Heinemeyer W., Kirk C.J., Groettrup M., Groll M. Immuno- and constitutive proteasome crystal structures reveal differences in substrate and inhibitor specificity. Cell 2012, 148:727-738.
3. Groettrup M., Ruppert T., Kuehn L., Seeger M., Standera S., Koszinowski U., Kloetzel P.M. The interferon-γ-inducible 11S regulator (PA28) and the LMP2/LMP7 subunits govern the peptide production by the 20S proteasome in vitro. J Biol Chem 1995, 270:23808-23815.
4. Toes R.E.M., Nussbaum A.K., Degermann S., Schirle M., Emmerich N.P.N., Kraft M., Laplace C., Zwinderman A., Dick T.P., Muller J., et al. Discrete cleavage motifs of constitutive and immunoproteasomes revealed by quantitative analysis of cleavage products. J Exp Med 2001, 194:1-12.
5. Schwarz K., van den Broek M., Kostka S., Kraft R., Soza A., Schmidtke G., Kloetzel P.M., Groettrup M Overexpression of the proteasome subunits LMP2 LMP7, and MECL-1 but not PA28α/β enhances the presentation of an immunodominant lymphocytic choriomeningitis virus T cell epitope. J Immunol 2000, 165:768-778.
6. Sijts A.J.A.M., Standera S., Toes R.E.M., Ruppert T., Beekman N.J.C.M., vanVeelen P.A., Ossendorp F.A., Melief C.J.M., Kloetzel PM MHC class I antigen processing of an Adenovirus CTL epitope is linked to the levels of immunoproteasomes in infected cells. J Immunol 2000, 164:4500-4506.
7. Basler M., Youhnovski N., Van Den Broek M., Przybylski M., Groettrup M Immunoproteasomes down-regulate presentation of a subdominant T cell epitope from lymphocytic choriomeningitis virus. J Immunol 2004, 173:3925-3934.
8. Basler M., Moebius J., Elenich L., Groettrup M., Monaco J.J. An altered T cell repertoire in MECL-1-deficient mice. J Immunol 2006, 176:6665-6672.
9. Chen W.S., Norbury C.C., Cho Y.J., Yewdell J.W., Bennink J.R. Immunoproteasomes shape immunodominance hierarchies of antiviral CD8(+) T cells at the levels of T cell repertoire and presentation of viral antigens. J Exp Med 2001, 193:1319-1326.
10. Groettrup M., Kirk C.J., Basler M. Proteasomes in immune cells: more than peptide producers?. Nat Rev Immunol 2010, 10:73-78.
11. Basler M., Beck U., Kirk C.J., Groettrup M. The antiviral immune response in mice devoid of immunoproteasome activity. J Immunol 2011, 187:5548-5557.
12. Osterloh P., Linkemann K., Tenzer S., Rammensee H.G., Radsak M.P., Busch D.H., Schild H. Proteasomes shape the repertoire of T cells participating in antigen-specific immune responses. Proc Natl Acad Sci USA 2006, 103:5042-5047.
13. Muchamuel T., Basler M., Aujay M.A., Suzuki E., Kalim K.W., Lauer C., Sylvain C., Ring E.R., Shields J., Jiang J., et al. A selective inhibitor of the immunoproteasome subunit LMP7 blocks cytokine production and attenuates progression of experimental arthritis. Nat Med 2009, 15:781-787.
14. Basler M., Dajee M., Moll C., Groettrup M., Kirk C.J. Prevention of experimental colitis by a selective inhibitor of the immunoproteasome. J Immunol 2010, 185:634-641.
15. Moebius J., van den Broek M., Groettrup M., Basler M. Immunoproteasomes are essential for survival and expansion of T cells in virus-infected mice. Eur J Immunol 2010, 40:3439-3449.
16. Kremer M., Henn A., Kolb C., Basler M., Moebius J., Guillaume B., Leist M., Van den Eynde B.J., Groettrup M. Reduced immunoproteasome formation and accumulation of immunoproteasomal precursors in the brains of lymphocytic choriomeningitis virus-infected mice. J Immunol 2010, 185:5549-5560.
17. Rock K.L., Gramm C., Rothstein L., Clark K., Stein R., Dick L., Hwang D., Goldberg A.L. Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell 1994, 78:761-771.
18. Basler M., Groettrup M. No essential role for tripeptidyl peptidase II for the processing of LCMV-derived T cell epitopes. Eur J Immunol 2007, 37:896-904.
19. Basler M., Lauer C., Beck U., Groettrup M. The proteasome inhibitor bortezomib enhances the susceptibility to viral infection. J Immunol 2009, 183:6145-6150.
20. de Verteuil D., Muratore-Schroeder T.L., Granados D.P., Fortier M.H., Hardy M.P., Bramoulle A., Caron E., Vincent K., Mader S., Lemieux S., et al. Deletion of immunoproteasome subunits imprints on the transcriptome and has a broad impact on peptides presented by major histocompatibility complex I molecules. Mol Cell Proteomics 2010, 9:2034-2047.
21. Zaiss D.M., de Graaf N., Sijts A.J. The proteasome immunosubunit multicatalytic endopeptidase complex-like 1 is a T-cell-intrinsic factor influencing homeostatic expansion. Infect Immun 2008, 76:1207-1213.
22. Hutchinson S., Sims S., O'Hara G., Silk J., Gileadi U., Cerundolo V., Klenerman P. A dominant role for the immunoproteasome in CD8+ T cell responses to murine cytomegalovirus. PLoS ONE 2011, 6:e14646.
23. Gileadi U., MoinsTeisserenc H.T., Correa I., Booth B.L., Dunbar P.R., Sewell A.K., Trowsdale J., Phillips R.E., Cerundolo V. Generation of an immunodominant CTL epitope is affected by proteasome subunit composition and stability of the antigenic protein. J Immunol 1999, 163:6045-6052.
24. Sijts A.J.A.M., Ruppert T., Rehermann B., Schmidt M., Koszinowski U., Kloetzel P.M. Efficient generation of a hepatitis B virus cytotoxic T lymphocyte epitope requires the structural features of immunoproteasomes. J Exp Med 2000, 191:503-513.
25. Basler M., Lauer C., Moebius J., Weber R., Przybylski M., Kisselev A.F., Tsu C., Groettrup M. Why the structure but not the activity of the immunoproteasome subunit low molecular mass polypeptide 2 rescues antigen presentation. J Immunol 2012, 189:1868-1877.
26. Guillaume B., Chapiro J., Stroobant V., Colau D., Van Holle B., Parvizi G., Bousquet-Dubouch M.P., Theate I., Parmentier N., Van den Eynde B.J. Two abundant proteasome subtypes that uniquely process some antigens presented by HLA class I molecules. Proc Natl Acad Sci USA 2010, 107:18599-18604.
27. Griffin T.A., Nandi D., Cruz M., Fehling H.J., VanKaer L., Monaco J.J., Colbert R.A. Immunoproteasome assembly: cooperative incorporation of interferon gamma (IFN-gamma)-inducible subunits. J Exp Med 1998, 187:97-104.
28. Groettrup M., Standera S., Stohwasser R., Kloetzel P.M. The subunits MECL-1 and LMP2 are mutually required for incorporation into the 20S proteasome. Proc Natl Acad Sci USA 1997, 94:8970-8975.
29. De M., Jayarapu K., Elenich L., Monaco J.J., Colbert R.A., Griffin T.A. Beta 2 subunit propeptides influence cooperative proteasome assembly. J Biol Chem 2003, 278:6153-6159.
30. Guillaume B., Stroobant V., Bousquet-Dubouch M.P., Colau D., Chapiro J., Parmentier N., Dalet A., Van den Eynde B.J. Analysis of the processing of seven human tumor antigens by intermediate proteasomes. J Immunol 2012, 189:3538-3547.
31. Kincaid E.Z., Che J.W., York I., Escobar H., Reyes-Vargas E., Delgado J.C., Welsh R.M., Karow M.L., Murphy A.J., Valenzuela D.M., et al. Mice completely lacking immunoproteasomes show major changes in antigen presentation. Nat Immunol 2012, 13:129-135.
32. Fehling H.J., Swat W., Laplace C., Kuehn R., Rajewsky K., Mueller U., von Boehmer H. MHC class I expression in mice lacking proteasome subunit LMP-7. Science 1994, 265:1234-1237.
33. Nussbaum A.K., Rodriguez-Carreno M.P., Benning N., Botten J., Whitton J.L. Immunoproteasome-deficient mice mount largely normal CD8+ T cell responses to lymphocytic choriomeningitis virus infection and DNA vaccination. J Immunol 2005, 175:1153-1160.
34. Hayashi T., Faustman D. NOD mice are defective in proteasome production and activation of NF-kappa B. Mol Cell Biol 1999, 19:8646-8659.
35. Hayashi T., Faustman D. Essential role of human leukocyte antigen-encoded proteasome subunits in NF-kappa B activation and prevention of tumor necrosis factor-alpha-induced apoptosis. J Biol Chem 2000, 275:5238-5247.
36. Runnels H.A., Watkins W.A., Monaco J.J. LMP2 expression and proteasome activity in NOD mice. Nat Med 2000, 6:1064-1065.
37. Kessler B.M., LennonDumenil A.M., Shinohara M.L., Lipes M.A., Ploegh H.L. LMP2 expression and proteasome activity in NOD mice. Nat Med 2000, 6:1064.
38. Jang E.R., Lee N.R., Han S., Wu Y., Sharma L.K., Carmony K.C., Marks J., Lee D.M., Ban J.O., Wehenkel M., et al. Revisiting the role of the immunoproteasome in the activation of the canonical NF-kappaB pathway. Mol Biosyst 2012, 8:2295-2302.
39. Pang K.C., Sanders M.T., Monaco J.J., Doherty P.C., Turner S.J., Chen W. Immunoproteasome subunit deficiencies impact differentially on two immunodominant influenza virus-specific CD8+ T cell responses. J Immunol 2006, 177:7680-7688.
40. Ichikawa H.T., Conley T., Muchamuel T., Jiang J., Lee S., Owen T., Barnard J., Nevarez S., Goldman B.I., Kirk C.J., et al. Novel proteasome inhibitors have a beneficial effect in murine lupus via the dual inhibition of type I interferon and autoantibody secreting cells. Arthritis Rheum 2012, 64:493-503.
41. Nagayama Y., Nakahara M., Shimamura M., Horie I., Arima K., Abiru N. Prophylactic and therapeutic efficacies of a selective inhibitor of the immunoproteasome for Hashimoto's thyroiditis, but not for Graves' hyperthyroidism, in mice. Clin Exp Immunol 2012, 168:268-273.
42. Fitzpatrick L.R., Khare V., Small J.S., Koltun W.A. Dextran sulfate sodium-induced colitis is associated with enhanced low molecular mass polypeptide 2 (LMP2) expression and is attenuated in LMP2 knockout mice. Dig Dis Sci 2006, 51:1269-1276.
43. Schmidt N., Gonzalez E., Visekruna A., Kuhl A.A., Loddenkemper C., Mollenkopf H., Kaufmann S.H., Steinhoff U., Joeris T. Targeting the proteasome: partial inhibition of the proteasome by bortezomib or deletion of the immunosubunit LMP7 attenuates experimental colitis. Gut 2010, 59:896-906.
44. Frausto R.F., Crocker S.J., Eam B., Whitmire J.K., Whitton J.L. Myelin oligodendrocyte glycoprotein peptide-induced experimental allergic encephalomyelitis and T cell responses are unaffected by immunoproteasome deficiency. J Neuroimmunol 2007, 192:124-133.
45. Seifert U., Bialy L.P., Ebstein F., Bech-Otschir D., Voigt A., Schroter F., Prozorovski T., Lange N., Steffen J., Rieger M., et al. Immunoproteasomes preserve protein homeostasis upon interferon-induced oxidative stress. Cell 2010, 142:613-624.
46. Opitz E., Koch A., Klingel K., Schmidt F., Prokop S., Rahnefeld A., Sauter M., Heppner F.L., Volker U., Kandolf R., et al. Impairment of immunoproteasome function by beta5i/LMP7 subunit deficiency results in severe enterovirus myocarditis. PLoS Pathog 2011, 7:e1002233.
47. Agarwal A.K., Xing C., DeMartino G.N., Mizrachi D., Hernandez M.D., Sousa A.B., Martinez de Villarreal A.B., dos Santos H.G., Garg A. PSMB8 encoding the beta5i proteasome subunit is mutated in joint contractures, muscle atrophy, microcytic anemia, and panniculitis-induced lipodystrophy syndrome. Am J Hum Genet 2010, 87:866-872.
48. Kitamura A., Maekawa Y., Uehara H., Izumi K., Kawachi I., Nishizawa M., Toyoshima Y., Takahashi H., Standley D.M., Tanaka K., et al. A mutation in the immunoproteasome subunit PSMB8 causes autoinflammation and lipodystrophy in humans. J Clin Invest 2011, 121:4150-4160.
49. Arima K., Kinoshita A., Mishima H., Kanazawa N., Kaneko T., Mizushima T., Ichinose K., Nakamura H., Tsujino A., Kawakami A., et al. Proteasome assembly defect due to a proteasome subunit beta type 8 (PSMB8) mutation causes the autoinflammatory disorder, Nakajo-Nishimura syndrome. Proc Natl Acad Sci USA 2011, 108:14914-14919.
50. Zaiss D.M., Bekker C.P., Grone A., Lie B.A., Sijts A.J. Proteasome immunosubunits protect against the development of CD8 T cell-mediated autoimmune diseases. J Immunol 2011, 187:2302-2309.
51. Groettrup M., Khan S., Schwarz K., Schmidtke G. Interferon-γ inducible exchanges of 20S proteasome active site subunits: Why?. Biochimie 2001, 83:367-372.
52. Kalim K.W., Basler M., Kirk C.J., Groettrup M. Immunoproteasome subunit LMP7 deficiency and inhibition suppresses Th1 and Th17 but enhances regulatory T cell differentiation. J Immunol 2012, 189:4182-4193.
53. Hensley S.E., Zanker D., Dolan B.P., David A., Hickman H.D., Embry A.C., Skon C.N., Grebe K.M., Griffin T.A., Chen W., et al. Unexpected role for the immunoproteasome subunit LMP2 in antiviral humoral and innate immune responses. J Immunol 2010, 184:4115-4122.
54. Rockwell C.E., Monaco J.J., Qureshi N. A critical role for the inducible proteasomal subunits LMP7 and MECL1 in cytokine production by activated murine splenocytes. Pharmacology 2012, 89:117-126.
55. Reis J., Hassan F., Guan X.Q., Shen J., Monaco J.J., Papasian C.J., Qureshi A.A., Van Way C.W., Vogel S.N., Morrison D.C., et al. The immunoproteasomes regulate LPS-induced TRIF/TRAM signaling pathway in murine macrophages. Cell Biochem Biophys 2011, 60:119-126.